NA
SMTI icon

NewEdge Advisors’s Sanara MedTech SMTI Stock Holding History

NewEdge Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Hold
758
– – ﹤0.01% 3389
2026
Q1 		$13K Sell
758
-9,631
-93% -$198K ﹤0.01% 3325
2025
Q4 		$243K Buy
+10,389
New +$268K ﹤0.01% 2462
2023
Q3 		– Sell
-73
Closed -$2.93K – 3638
2023
Q2 		$2.93K Buy
+73
New +$2.99K ﹤0.01% 2979

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

NewEdge Advisors's SMTI Position: Q2 2026 in Review

NewEdge Advisors held its Sanara MedTech (SMTI) position steady in Q2 2026 at 758 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3389.

NewEdge Advisors first reported a position in SMTI in Q2 2023 and has held it in 4 quarters since. The position peaked at $243K in Q4 2025. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • NewEdge Advisors held 758 shares of Sanara MedTech worth $17.9K as of Q2 2026.
  • NewEdge Advisors left its Sanara MedTech share count unchanged in Q2 2026.
  • Sanara MedTech made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3389 holding.
  • NewEdge Advisors first reported a position in Sanara MedTech in Q2 2023 and has held it in 4 quarters since.
  • NewEdge Advisors's Sanara MedTech position peaked at $243K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.